Drotaverine

Drotaverine
	File:Drotaverine.svg
Clinical data
Routes of; administration	Oral, intravenous
ATC code	A03AD02 (WHO) ;
Pharmacokinetic data
Bioavailability	Highly variable
Protein binding	80 to 95%
Metabolism	Hepatic
Elimination half-life	7 to 12 hours
Excretion	Fecal and renal
Identifiers
	IUPAC name (1Z)-1-[(3,4-diethoxyphenyl)methylidene]-6,7-; diethoxy-3,4-dihydro-2H-isoquinoline;
CAS Number	985-12-6;
PubChem CID	1712095;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C24H31NO4
Molar mass	397.507 g/mol

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Drotaverine (INN, also known as drotaverin) is an antispasmodic drug, structurally related to papaverine. Drotaverine is a selective inhibitor of phosphodiesterase 4, and has no anticholinergic effects.

A small 2003 study found drotaverine to be nearly 80% effective in treating renal colic.^[1] It has also been used to accelerate labor.^[2]

References

↑ Romics I, Molnár DL, Timberg G; et al. (2003). "The effect of drotaverine hydrochloride in acute colicky pain caused by renal and ureteric stones". BJU Int. 92 (1): 92–6. doi:10.1046/j.1464-410X.2003.04262.x. PMID 12823389.
↑ Singh KC, Jain P, Goel N, Saxena A (2004). "Drotaverine hydrochloride for augmentation of labor". Int J Gynaecol Obstet. 84 (1): 17–22. PMID 14698825.

Template:Pharmacology-stub Template:Drugs for functional gastrointestinal disorders

[1] Romics I, Molnár DL, Timberg G; et al. (2003). "The effect of drotaverine hydrochloride in acute colicky pain caused by renal and ureteric stones". BJU Int. 92 (1): 92–6. doi:10.1046/j.1464-410X.2003.04262.x. PMID 12823389.

[2] Singh KC, Jain P, Goel N, Saxena A (2004). "Drotaverine hydrochloride for augmentation of labor". Int J Gynaecol Obstet. 84 (1): 17–22. PMID 14698825.

[1]

[2]

Clinical data
File:Drotaverine.svg
Routes of administration	Oral, intravenous
ATC code	A03AD02 (WHO)
Pharmacokinetic data
Bioavailability	Highly variable
Protein binding	80 to 95%
Metabolism	Hepatic
Elimination half-life	7 to 12 hours
Excretion	Fecal and renal
Identifiers
IUPAC name (1Z)-1-[(3,4-diethoxyphenyl)methylidene]-6,7- diethoxy-3,4-dihydro-2H-isoquinoline
CAS Number	985-12-6
PubChem CID	1712095
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₂₄H₃₁NO₄
Molar mass	397.507 g/mol

Drotaverine

References

Navigation menu